151 related articles for article (PubMed ID: 38379179)
1. Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Bromberg DJ; Machavariani E; Madden LM; Dumchev K; LaMonaca K; Earnshaw VA; Pykalo I; Filippovych M; Haddad MS; Dvoriak S; Altice FL
J Int AIDS Soc; 2024 Feb; 27(2):e26202. PubMed ID: 38379179
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
3. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Morozova O; Dvoriak S; Pykalo I; Altice FL
Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
[TBL] [Abstract][Full Text] [Related]
4. Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study.
Sereda Y; Kiriazova T; Makarenko O; Carroll JJ; Rybak N; Chybisov A; Bendiks S; Idrisov B; Dutta A; Gillani FS; Samet JH; Flanigan T; Lunze K
J Int AIDS Soc; 2020 May; 23(5):e25492. PubMed ID: 32372534
[TBL] [Abstract][Full Text] [Related]
5. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
[TBL] [Abstract][Full Text] [Related]
7. Successful transfer of stable patients on opioid agonist therapies from specialty addiction treatment to primary care settings in Ukraine: A pilot study.
Meteliuk A; Galvez S; Fomenko T; Kalandiia H; Iaryi V; Farnum SO; Islam Z; Altice FL; Madden LM
J Subst Abuse Treat; 2022 Mar; 134():108619. PubMed ID: 34579978
[TBL] [Abstract][Full Text] [Related]
8. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
Tan J; Altice FL; Madden LM; Zelenev A
Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
[TBL] [Abstract][Full Text] [Related]
9. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data.
Meteliuk A; Prokhorova T; Filippovych S; Ompad DC; Zaller N
Drug Alcohol Depend; 2020 Nov; 216():108216. PubMed ID: 32805547
[TBL] [Abstract][Full Text] [Related]
10. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
11. Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine.
Machavariani E; Bromberg DJ; Dumchev K; Dvoriak S; Zeziulin O; Morozova O; Esserman D; Pykalo I; Saichuk N; Ivasiy R; Haddad MS; Altice FL
Contemp Clin Trials; 2023 Aug; 131():107248. PubMed ID: 37263492
[TBL] [Abstract][Full Text] [Related]
12. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis.
Lancaster KE; Hoffman IF; Hanscom B; Ha TV; Dumchev K; Susami H; Rose S; Go VF; Reifeis SA; Mollan KR; Hudgens MG; Piwowar-Manning EM; Richardson P; Dvoriak S; Djoerban Z; Kiriazova T; Zeziulin O; Djauzi S; Ahn CV; Latkin C; Metzger D; Burns DN; Sugarman J; Strathdee SA; Eshleman SH; Clarke W; Donnell D; Emel L; Sunner LE; McKinstry L; Sista N; Hamilton EL; Lucas JP; Duong BD; Van Vuong N; Sarasvita R; Miller WC;
J Int AIDS Soc; 2018 Oct; 21(10):e25195. PubMed ID: 30350406
[TBL] [Abstract][Full Text] [Related]
13. Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.
Zelenev A; Shea P; Mazhnaya A; Rozanova J; Madden L; Marcus R; Altice FL
Drug Alcohol Depend; 2018 Sep; 190():82-88. PubMed ID: 29990648
[TBL] [Abstract][Full Text] [Related]
14. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
[TBL] [Abstract][Full Text] [Related]
15. The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.
Bojko MJ; Mazhnaya A; Marcus R; Makarenko I; Islam Z; Filippovych S; Dvoriak S; Altice FL
J Subst Abuse Treat; 2016 Jul; 66():37-47. PubMed ID: 27211995
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
17. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
[TBL] [Abstract][Full Text] [Related]
18. M
Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
[TBL] [Abstract][Full Text] [Related]
19. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
20. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]